Anti‐inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy
Open Access
- 1 June 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 118 (3), 811-819
- https://doi.org/10.1111/j.1476-5381.1996.tb15472.x
Abstract
1 The aim of this study was to examine the effect of theophylline, cromolyn and salbutamol, three well-known anti-asthmatic drugs, on the early (4 h) and late (48 h) phases of cell migration and fluid leakage induced by carrageenin in the pleural cavity of mice. 2 In the first set of experiments, animals were pretreated (30 min) with different doses of theophylline (0.5–50 mg kg−1, i.p.), cromolyn (0.02–0.2 mg per pleural cavity) or salbutamol (0.05–50 mg kg−1, i.p.); the total and differential cell content, and also the exudate were analysed 4 h after carrageenin (1%) administration. Afterwards, in order to evaluate the time course effects of these drugs on both phases of the inflammatory reaction, one dose employed in the above protocol was chosen, to pretreat (0.5–24 h) different groups of animals. The studied parameters were evaluated 4 and 48 h after pleurisy induction. 3 Acute administration of theophylline (1–50 mg kg−1, i.p.), cromolyn (0.02-0.2 mg per pleural cavity) and salbutamol (0.5–50 mg kg−1, i.p.), 30 min prior to carrageenin, caused significant inhibition of total cell and fluid leakage in the pleural cavity at 4 h (P < 0.01). All drugs exerted a long-lasting inhibitory effect on both exudation and cell migration (P < 0.01) when administered 0.5–8 h before pleurisy induction. However, the temporal profile of the inhibitory effect induced by these drugs on the first phase of the inflammatory reaction was clearly different. Thus, the inhibitory effect induced by theophylline and cromolyn on exudation was significantly longer (up to 24 h) in comparison to their effects on cell migration (only up to 8 h). In contrast, although salbutamol when administered 30 min before pleurisy induction abolished fluid leakage (P < 0.01), this effect was not sustained in the groups pretreated for 4–8 h. In these latter groups, a significant but much smaller reduction of exudation was observed (P < 0.01), whereas the magnitude of cell migration inhibition did not vary. 4 The second phase (48 h) of the inflammatory reaction induced by carrageenin (1%) was significantly inhibited by cromolyn (0.02 mg per pleural cavity) when this drug was administered 0.5–24 h before pleurisy induction (P < 0.01). Similar results were observed when theophylline (50 mg kg−1, i.p.) was administered 0.5-4 h before the injection of the phlogistic agent (P < 0.01). Treatment of the animals with salbutamol (5 mg kg−1, i.p.), 0.5–24 h before pleurisy induction, did not inhibit either cell migration or fluid leakage. In this condition, a significant increase of these parameters was observed in the group pretreated with salbutamol 8–24 h before pleurisy induction (P < 0.01). 5 These results indicate that theophylline and cromolyn were able to inhibit the early (4 h) and late (48 h) phases of the inflammatory reaction induced by carrageenin in a murine model of pleurisy. Salbutamol was effective only against the early phase. The inhibitory effects of theophylline, cromolyn and salbutamol on the early phase of this inflammatory reaction were long-lasting, although a distinct profile of inhibition was observed among them. These findings confirm and extend previous results described in other models of asthma and support both clinical and experimental evidence suggesting that these anti-asthmatic agents exhibit marked anti-inflammatory properties.Keywords
This publication has 40 references indexed in Scilit:
- Theophylline suppresses the release of tumour necrosis factor-alpha by blood monocytes and alveolar macrophagesEuropean Respiratory Journal, 1994
- Theophylline Target Concentration in Severe Airways Obstruction - 10 or 20 mg/L?Clinical Pharmacokinetics, 1993
- Nedocromil sodium blocks the early and late phases of allergen challenge in a guinea pig model of asthmaJournal of Allergy and Clinical Immunology, 1993
- Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapyEuropean Journal of Clinical Investigation, 1992
- Pharmacological modulation of a model of bronchial inflammation after aerosol-induced active anaphylactic shock in conscious guinea pigsInternational Journal of Immunopharmacology, 1991
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Mechanistic aspects of cromolyn sodium action on the alveolar macrophage: Inhibition of stimulation by soluble agonistsInflammation Research, 1991
- The human skin mast cell: A comparison with the human lung cell and a novel mast cell type, the uterine mast cellInflammation Research, 1991
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- New aspects of the therapeutic potential of theophylline in asthmaJournal of Allergy and Clinical Immunology, 1989